SCHEMBL7303712

SCHEMBL7303712

C=C(CCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
KEAP1 Q14145 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
KMT2A Q03164 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 1/20 0.45
HTT P42858 1/20 0.45
FFAR1 O14842 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 1/20 0.43
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27871609 0.84 ALDH1A1 (0.46) ALDH1A1KEAP1TDP1KMT2AL3MBTL1
SCHEMBL7060693 0.83 ALDH1A1 (0.52) ALDH1A1KEAP1TDP1KMT2AL3MBTL1
SCHEMBL4976027 0.83 CES1 (0.44) ALDH1A1KMT2AL3MBTL1MEN1HDAC8
SCHEMBL7414176 0.82 L3MBTL1 (0.49) ALDH1A1L3MBTL1HTTCA12CA1
SCHEMBL3997663 0.81 ALDH1A1 (0.53) ALDH1A1KEAP1TDP1HTTFFAR1
SCHEMBL21805717 0.80 L3MBTL1 (0.53) L3MBTL1HTTSMN1; SMN2CTSSIDO1
SCHEMBL1380801 0.80 TDP1 (0.61) ALDH1A1KEAP1TDP1KMT2AL3MBTL1
SCHEMBL7299043 0.79 MAPT (0.53) ALDH1A1KEAP1TDP1KMT2AL3MBTL1
SCHEMBL7061341 0.78 ALDH1A1 (0.46) ALDH1A1KEAP1TDP1KMT2AL3MBTL1
SCHEMBL3291001 0.78 KEAP1 (0.52) ALDH1A1KEAP1TDP1HTTFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733642-B1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions SOLVAY PHARM GMBH (DE) 2000-11-29 EP disclosed
EP-0830863-B1 Drugs for increasing gastrointestinal blood supply SOLVAY PHARM GMBH (DE) 2000-05-10 EP disclosed
US-5783573-A Pharmaceuticals which promote gastrointestinal blood circulation SOLVAY PHARMACEUTICALS GMBH (DE) 1998-07-21 US disclosed
EP-0830863-A1 Drugs for increasing gastrointestinal blood supply Solvay Pharmaceuticals GmbH (DE) 1998-03-25 EP disclosed
US-5679700-A STROMELYSIN INHIBITOR MERCK & CO., INC. (US) 1997-10-21 US disclosed
US-5677297-A ENZYME INHIBITOR FOR TREATING THE HEART FAILURE TO REDUCE THE CARDIAC PRESSURE, DIURETICS SOLVAY PHARMACEUTICALS GMBH (DE) 1997-10-14 US disclosed
EP-0733642-A1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions Kali-Chemie Pharma GmbH (DE) 1996-09-25 EP disclosed
US-5389610-A For cardiovascular disorders SCHERING CORPORATION (US) 1995-02-14 US disclosed
WO-1993014112-A1 SUBSTITUTED PHOSPHINIC ACID-CONTAINING PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1993-07-22 WO disclosed
EP-0502075-A1 CARBOXYALKYLCARBONYL AMINOACID ENDOPEPTIDASE INHIBITORS SCHERING CORPORATION (US) 1992-09-09 EP disclosed
WO-1991007386-A1 CARBOXYALKYLCARBONYL AMINOACID ENDOPEPTIDASE INHIBITORS SCHERING CORPORATION (US) 1991-05-30 WO disclosed
US-4866087-A HYPOTENSIVE AGENTS MERCK & CO., INC. (US) 1989-09-12 US disclosed
US-4402969-A UREA ANALOGS OF DIPEPTIDES MERCK & CO., INC. (US) 1983-09-06 US disclosed
EP-0061684-A1 Urea compounds as antihypertensives MERCK & CO. INC. (US) 1982-10-06 EP disclosed